These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34488117)

  • 41. Advances in the research of nano delivery systems in ischemic stroke.
    Li YX; Wang HB; Jin JB; Yang CL; Hu JB; Li J
    Front Bioeng Biotechnol; 2022; 10():984424. PubMed ID: 36338131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid antagonists as potential therapeutics for ischemic stroke.
    Peyravian N; Dikici E; Deo S; Toborek M; Daunert S
    Prog Neurobiol; 2019 Nov; 182():101679. PubMed ID: 31398359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polyphenols for the Treatment of Ischemic Stroke: New Applications and Insights.
    Liu S; Lin F; Wang J; Pan X; Sun L; Wu W
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombus Inhibition and Neuroprotection for Ischemic Stroke Treatment through Platelet Regulation and ROS Scavenging.
    Ye H; Ma Z; Liu L; Zhang T; Han Q; Xiang Z; Xia Y; Ke Y; Guan X; Shi Q; Ataullakhanov FI; Panteleev M
    ChemMedChem; 2022 Dec; 17(24):e202200317. PubMed ID: 36220787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases.
    Farhoudi M; Sadigh-Eteghad S; Mahmoudi J; Farjami A; Mahmoudian M; Salatin S
    Curr Pharm Des; 2022; 28(24):1985-2000. PubMed ID: 35676838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke.
    Jin W; Wu Y; Chen N; Wang Q; Wang Y; Li Y; Li S; Han X; Yang E; Tong F; Wu J; Yuan X; Kang C
    Theranostics; 2021; 11(17):8197-8217. PubMed ID: 34373737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recanalization and reperfusion therapies for acute ischemic stroke.
    Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows.
    González-Nieto D; Fernández-Serra R; Pérez-Rigueiro J; Panetsos F; Martinez-Murillo R; Guinea GV
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier.
    Tornabene E; Brodin B
    J Pharm Sci; 2016 Feb; 105(2):398-405. PubMed ID: 26869407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment with Atorvastatin During Vascular Remodeling Promotes Pericyte-Mediated Blood-Brain Barrier Maturation Following Ischemic Stroke.
    Yang Y; Yang LY; Salayandia VM; Thompson JF; Torbey M; Yang Y
    Transl Stroke Res; 2021 Oct; 12(5):905-922. PubMed ID: 33423214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiRNA: Involvement of the MAPK Pathway in Ischemic Stroke. A Promising Therapeutic Target.
    Gugliandolo A; Silvestro S; Sindona C; Bramanti P; Mazzon E
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatments in Ischemic Stroke: Current and Future.
    Mosconi MG; Paciaroni M
    Eur Neurol; 2022; 85(5):349-366. PubMed ID: 35917794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. microRNA as a therapeutic for ischemic stroke.
    Todoran R; Falcione SR; Clarke M; Joy T; Boghozian R; Jickling GC
    Neurochem Int; 2023 Feb; 163():105487. PubMed ID: 36657721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A biomimetic zeolite-based nanoenzyme contributes to neuroprotection in the neurovascular unit after ischaemic stroke via efficient removal of zinc and ROS.
    Huang Z; Qian K; Chen J; Qi Y; E Y; Liang J; Zhao L
    Acta Biomater; 2022 May; 144():142-156. PubMed ID: 35296444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
    Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
    Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
    Liu S; Feng X; Jin R; Li G
    Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxygen-Generating Cyanobacteria Powered by Upconversion-Nanoparticles-Converted Near-Infrared Light for Ischemic Stroke Treatment.
    Wang J; Su Q; Lv Q; Cai B; Xiaohalati X; Wang G; Wang Z; Wang L
    Nano Lett; 2021 Jun; 21(11):4654-4665. PubMed ID: 34008994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ischemic brain edema: Emerging cellular mechanisms and therapeutic approaches.
    Han W; Song Y; Rocha M; Shi Y
    Neurobiol Dis; 2023 Mar; 178():106029. PubMed ID: 36736599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preclinical animal studies in ischemic stroke: Challenges and some solutions.
    Narayan SK; Grace Cherian S; Babu Phaniti P; Babu Chidambaram S; Rachel Vasanthi AH; Arumugam M
    Animal Model Exp Med; 2021 Jun; 4(2):104-115. PubMed ID: 34179718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential nanotherapeutic strategies for perioperative stroke.
    An J; Zhao L; Duan R; Sun K; Lu W; Yang J; Liang Y; Liu J; Zhang Z; Li L; Shi J
    CNS Neurosci Ther; 2022 Apr; 28(4):510-520. PubMed ID: 35243774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.